Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 08:00 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...